- $43.61m
- $49.39m
- $0.65m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0.206 | 0.723 | 0.473 | 0.654 |
Cost of Revenue | |||||
Gross Profit | — | 0.141 | 0.434 | 0.447 | 0.533 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 0.588 | 21 | 50.1 | 48.9 | 41.2 |
Operating Profit | -0.588 | -20.8 | -49.3 | -48.4 | -40.5 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 0.269 | -18.9 | -10.2 | -29.9 | -49.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | 0.269 | -19.3 | -9.74 | -29.9 | -49.5 |
Net Income Before Extraordinary Items | |||||
Net Income | 0.269 | -19.3 | -9.74 | -29.9 | -49.5 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.45 | -19.3 | -9.74 | -29.9 | -49.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -4.28 | -21.7 | -3.3 | -9.31 | -9.43 |